Status:
COMPLETED
Retrospective Observational Study of Cotrimoxazole Dosing in Intensive Care Unit
Lead Sponsor:
Centre Hospitalier Universitaire de Saint Etienne
Conditions:
Acute Kidney Injury
Eligibility:
All Genders
18+ years
Brief Summary
Trimethoprim/sulfamethoxazole (TMP/SMX, cotrimoxazole) is the first-line therapy for Pneumocystis jirovecii pneumonia and bacterial infections in critically ill patients, where acute kidney injury (AK...
Detailed Description
The objective is to compare the plasma concentrations of patients with acute renal failure (ARF) or requiring extra renal replacement therapy (RRT) with those of patients without these characteristics...
Eligibility Criteria
Inclusion
- Patient hospitalized in Intensive Care Units between October 2020 and July 2021 with infection treated with cotrimoxazole
Exclusion
- None
Key Trial Info
Start Date :
October 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 15 2021
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT05221216
Start Date
October 15 2021
End Date
November 15 2021
Last Update
February 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Saint-Etienne
Saint-Etienne, France